# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-25-058841
Filing Date
2025-04-25
Accepted
2025-04-25 17:00:18
Documents
19
Period of Report
2025-06-04

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | fgen-20250425.htm iXBRL | DEF 14A | 1469090
2 | GRAPHIC | img66612491_0.jpg | GRAPHIC | 249357
3 | GRAPHIC | img66612491_1.jpg | GRAPHIC | 76493
4 | GRAPHIC | img66612491_2.jpg | GRAPHIC | 74413
5 | GRAPHIC | img66612491_3.jpg | GRAPHIC | 2635823
6 | GRAPHIC | img66612491_4.jpg | GRAPHIC | 2152925
| Complete submission text file | 0000950170-25-058841.txt |  | 14563817

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | fgen-20250425.xsd | EX-101.SCH | 39424
22 | EXTRACTED XBRL INSTANCE DOCUMENT | fgen-20250425_htm.xml | XML | 500099

Mailing Address 350 BAY STREET SUITE 100 #6009 SAN FRANCISCO CA 94133
Business Address 350 BAY STREET SUITE 100 #6009 SAN FRANCISCO CA 94133 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36740 | Film No.: 25875043
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)